Sunday, December 22, 2024
12/22/2024
Flushing Hospital Medical Center (FHMC), located in Queens, New York (NY), proposes to continue operation of the Flushing CCBHC in collaboration with 7 partners. The proposed project, Flushing CCBHC-IA, will provide behavioral health services (psychiatric and substance use disorders [SUD]) to any individual who seeks care. A sub-population of focus includes individuals across the lifespan who belong to non-White minority groups. FHMC, with Arms Acres, NYC Health+Hospitals/Elmhurst, Jamaica Hospital Medical Center, NADAP, the NY State Office of Mental Health NY City Field Office for ACT, the United State Department of Veterans Affairs VA NY Harbor Healthcare System, and Transitional Services for NY, proposes the following: Goal 1: Together with partners, continue to provide access to culturally and linguistically competent, community-based mental health and SUD treatment and support, including 24/7 crisis services as a CCBHC. Obj. 1.1: By Month 4, update MOUs, as applicable, with Designated Collaborating Organizations (DCO) to provide services that are not provided by FHMC. Obj. 1.2: Maintain CCBHC certification. Obj. 1.3: At least 500 patients with SMI, CODs, or SUD will receive CCBHC services by the end of the project period. Obj. 1.4: Increase representation of consumers on the Flushing CCBHC Advisory Council by adding three Peer Advocates with lived experience to further improve operations. • Goal 2: Improve treatment compliance and follow-up for patients with SUD treated at the Flushing CCBHC, particularly for those in minority groups. Obj. 1.1: Reduce the percentage of patients that leave the FHMC inpatient Chemical Dependency Unit Against Medical Advice (AMA) from 35% to 25%. Obj. 1.2: At least 70% of SUD patients referred for psychiatric rehabilitation services after detox will receive direct contact from CCBHC staff to confirm initiation of and improve retention in treatment. Obj. 1.3: Maintain Ancillary Withdrawal Management program according to NYS OASAS protocols. Obj. 1.4: Improve validity and reliability of patient demographic data collected in Epic to 100% through a cross-reference of patient surveys and Epic data by the end of the project period. • Goal 3: Improve health outcomes for minority patients with SMI and SUD, and for patients who are at increased risk for diabetes, metabolic syndrome, cardiovascular and respiratory diseases, HIV, and Viral Hepatitis. Obj. 3.1: 100% of patients with SMI who are using antipsychotic medications will be screened for diabetes. Obj. 3.2: 100% of patients will be screened for tobacco use and receive a cessation intervention. Obj. 3.3: Monthly, generate one Epic report each for patients with diabetes, hypertension, chronic obstructive pulmonary disease (COPD), and other COD to provide opportunities for enhanced care to specialized groups of patients. Obj. 3.4: Monthly, generate one Epic report based on race/ethnicity, to provide opportunities for enhanced care to minority patients. • Goal 4: Continue to expand prevention services for patients at risk for OUD; improve access to OUD treatment services and improve treatment outcomes for patients with OUD. Obj. 4.1: 100% of CCBHC health care providers will obtain and maintain a buprenorphine waiver. Obj. 4.2: At least 50% of clinic patients with OUD will receive MAT. This program will serve 200 individuals in Year 1, and 100 individuals annually in Years 2-4, totaling 500 unduplicated individuals over the 4-year budget period.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).